NAUT
Nautilus Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.90
−1.59%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 71.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.88x
- Price / sales
- 606.07x
- Price / cash flow
- -2.29x
Enterprise value
- Enterprise value
- $58.9M
- EV / sales
- 310.20x
- EV / EBITDA
- -1.07x
- EV / EBIT
- -0.94x
- Market cap
- $115.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026